PETALING JAYA: The government will not be vaccinating anyone aged 17 and below for now to prevent any risks associated with heart inflammation.
“This includes SPM candidates (and is meant to) prevent any risk of myocarditis and pericarditis (inflammation of the outer layer of the heart) as reported by teenagers in the United States who have received their second dose of Covid-19 vaccines,” said the Covid-19 immunisation task force today.
In a statement to FMT last month, health director general Dr Noor Hisham Abdullah said that to date, there are no reports of adverse events following immunisation (AEFI) specific to myocarditis/pericarditis received by the health ministry or the National Pharmaceutical Regulatory Agency (NPRA).
“Evaluation is still under way to determine the relationship of this issue to mRNA-type vaccines,” he added.
Earlier this month, health minister Dr Adham Baba said the government had agreed to only administer the Pfizer vaccine to adolescents with underlying medical conditions for now.
Such conditions include cancer, chronic lung disease or other comorbidities, such as diabetes.-FMT